Poly(choloyl)-Based Amphiphiles
A R T I C L E S
396 H), 0.69 (s, 36 H). MALDI-TOF MS m/z 6099 ([M + Na]+). The
sample was judged to be homogeneous based on the appearance of a
single TLC spot (developed by two or more eluents) and a comparison
of the integrated NMR signals for the lysine protons (4.54-4.25 ppm)
relative to the 3-position protons of choloyl units (3.93 ppm).
After removal of solvent under reduced pressure, the deprotected
product (appearing as an oil) was used directly in the next step. To a
solution of cholic acid (410 mg, 1 mmol) in anhydrous DMF (5 mL)
was added DHBT (200 mg, 1.2 mmol) and DCC (240 mg, 1.2 mmol).
After stirring the mixture for 3 h at room temperature, the deprotected
form of 13 and triethylamine (0.1 mL) were added. The reaction mixture
was stirred overnight at room temperature and then poured into diluted
aqueous HCl (50 mL). The resulting precipitate was collected by
filtration and purified by chromatography on a silica gel column, eluting
with CHCl3/CH3OH/H2O (65/25/4, v/v/v), to give 5 (112 mg, 36%).
1H NMR (CD3OD, 500 MHz) δ: 4.26 (br, 4 H), 3.95 (br, 8 H), 3.81
(s, 8 H), 3.35-3.30 (br, 16 H), 3.18 (br, 12 H), 2.30-1.40 (m, 242 H),
1.05-0.92 (m, 64 H), 0.72 (s, 24 H). MALDI-TOF MS m/z 3862 ([M
+ Na]+). The sample was judged to be homogeneous based on the
appearance of a single TLC spot (developed by two or more eluents)
and a comparison of the integrated NMR signal for the lysine protons
(4.26 ppm) relative to the 3-position protons of choloyl units (3.95
ppm).
Compound 10. To a solution of 1,4-diaminobutane (57 mg, 0.65
mmol) and triethylamine (0.5 mL) in anhydrous DMF-THF (4 mL,
1/1, v/v) was added Boc-L-Lys(Boc)-OSu (620 mg, 1.40 mmol). The
resulting suspension was stirred at room temperature for 24 h. Removal
of solvent under reduced pressure and purification by chromatography
on a silica gel column, eluting with CHCl3/MeOH (10/1, v/v), gave 10
1
(432 mg, 90%). H NMR (500 MHz, CDCl3, 298K) δ: 6.89 (br, 2H,
CONH), 5.29 (br, 2 H, CONH), 4.67 (br, 2 H, CONH), 4.06
(unresolved, 2 H), 3.36 (unresolved, 2 H), 3.08-3.07 (unresolved, 6
H), 1.75-1.28 (m, 52 H). MALDI-TOF MS m/z 767 ([M + Na]+).
Conjugate 4. A solution of 10 (50 mg, 0.067 mmol) and trifluoro-
acetic acid (1 mL) was stirred at room temperature for 1 h. The reaction
mixture was concentrated under reduced pressure, and the residue (11)
was dried under vacuum for 4 h and used directly in the following
reaction without further purification. The complete removal of Boc
Compound 14. To a solution of 1,4-phenylenediamine (20 mg, 0.19
mmol) and triethylamine (0.30 mL) in anhydrous THF (2 mL) was
added Boc-L-Lys(Boc)-OSu (205 mg, 0.46 mmol). After the reaction
mixture was stirred at room temperature for 24 h, another portion of
Boc-L-Lys(Boc)-OSu (100 mg, 0.23 mmol) was added. The reaction
was stirred for an additional 48 h. The reaction mixture was concen-
trated under reduced pressure, and the residue was purified by
chromatography on a silica gel column, eluting with CHCl3/MeOH
1
groups, giving 11, was confirmed by H NMR (500 MHz, CD3OD,
3
298 K) δ: 3.84 (t, 2 H, J ) 6.63 and 6.63 Hz), 3.26-3.20 (m, 4 H),
2.93 (t, 4 H, 3J ) 7.66 and 7.79 Hz), 1.93-1.80 (m, 4 H), 1.73-1.68
(m, 4 H), 1.59-1.53 (m, 4 H), 1.49-1.43 (m, 4 H).
To a solution of L-lysine-dicholamide (311 mg, 0.335 mmol) and
DHBT (68 mg, 0.417 mmol) in anhydrous DMF (1 mL) was added
DCC (108 mg, 0.523 mmol). After stirring for 3 h, a solution of 11,
which was prepared from 10 (50 mg, 0.067 mmol), and triethylamine
(0.5 mL) in anhydrous DMF (1 mL) was added. The mixture was stirred
for 24 h and then poured into 1 M hydrochloride acid (200 mL). The
resulting precipitate was collected by filtration and purified twice by
chromatography on a silica gel column, eluting with CHCl3/CH3OH/
1
(40/1, v/v), to give 14 (125 mg, 88%). H NMR (500 MHz, CD3OD,
323 K) δ: 7.49 (s, 4 H), 4.12 (br, 2 H), 3.04 (t, 3J ) 6.66 and 6.76 Hz,
4 H), 1.79-1.37 (m, 48 H). MALDI-TOF MS m/z 787 ([M + Na]+).
Conjugate 6. A solution of 14 (50 mg, 0.065 mmol) in trifluoroacetic
acid (2 mL) was stirred at room temperature for 2 h and then
concentrated under reduced pressure. Removal of solvent under reduced
pressure and drying under vacuum for 4 h gave 15, which was used
directly without further purification. The complete removal of the Boc
groups was confirmed by 1H NMR (500 MHz, CD3OD, 298 K) δ: 7.59
1
H2O (40/10/1, v/v), to give 4 (120 mg, 45%). H NMR (500 MHz,
CD3OD, 323 K) δ: 4.27 (m, 6 H), 3.94 (s, 8 H), 3.79 (s, 8 H), 3.36-
3.39 (m, 8 H), 3.20-3.15 (m, 16 H), 2.29-0.91 (m, 280 H), 0.70 (s,
24 H). MALDI-TOF MS m/z 4004 ([M + Na]+). The sample was
judged to be homogeneous based on the appearance of a single TLC
spot (developed by two or more eluents) and a comparison of the
integrated NMR signals for the lysine protons (4.27 ppm) relative to
the 3-position protons of choloyl units (3.94 ppm).
3
3
(s, 4H), 4.03 (t, 2 H, J ) 6.60 and 6.50 Hz), 2.93 (t, 4 H, J ) 7.55
and 7.85 Hz), 2.01-1.95 (m, 4 H), 1.74-1.69 (m, 4 H), 1.561.51 (m,
4 H).
To a solution of L-lysine-dicholamide (290 mg, 0.31 mmol) and
DHBT (64 mg, 0.39 mmol) in anhydrous DMF (2 mL) was added DCC
(100 mg, 0.51 mmol). After the mixture was stirred for 3 h, a solution
of 15, which was prepared from 14 (50 mg, 0.065 mmol), and
triethylamine (0.5 mL) in anhydrous DMF (0.5 mL) was added. The
reaction mixture was stirred at room temperature for 24 h and then
poured into 1 M hydrochloride acid (150 mL). The resulting precipitate
was collected by filtration and purified twice by chromatography on a
silica gel column, eluting with CHCl3/CH3OH/H2O (40/10/1, v/v/v),
Compound 12. To a solution of L-lysine-dicholamide (3.7 g, 4
mmol) in anhydrous DMF (10 mL) was added DHBT (1 g, 6.4 mmol)
and DCC (825 mg, 4 mmol). After stirring for 3 h at room temperature,
Boc-L-Lys-OH (790 mg, 3.2 mmol) and triethylamine (0.2 mL) were
added. The reaction mixture was stirred for 12 h at room temperature
and then poured into diluted aqueous HCl (50 mL). The resulting
precipitate was collected by filtration and purified by chromatography
on a silica gel column, eluting with CHCl3/CH3OH/H2O (65/25/4, v/v/
1
to give 6 (147 mg, 56%). H NMR (500 MHz, CD3OD, 328 K) δ:
1
v), to give 12 (2.51 g, 68%). H NMR (CD3OD, 500 MHz) δ: 4.25
7.69 (unsolved, 2H), 7.56 (unsolved, 2H), 4.44 (unresolved, 2 H), 4.31
and 4.23 (unresolved, 4 H), 3.94 (s, 8 H), 3.79 (s, 8 H), 3.36-3.34 (m,
8 H), 3.15 (m, 12 H), 2.29-0.91 (m, 276 H), 0.70 (s, 24 H). MALDI-
TOF MS m/z 4024 ([M + Na]+). The sample was judged to be
homogeneous based on the appearance of a single TLC spot (developed
by two different eluents) and a comparison of the integrated NMR
signals for the lysine protons (4.44-4.23 ppm) relative to the 3-position
protons of choloyl units (3.94 ppm).
Vesicle Formation and Na+/K+ Transport Measurements. Typi-
cally, 2.5 mL of a 20 mg/mL solution of 1-palmitoyl-2-oleoyl-2-sn-
glycero-3-phosphocholine (POPC) in chloroform was transferred to a
Pyrex test tube. The desired amount of pore-forming conjugate was
then added from a stock solution in methanol. While rotating the tube,
the organic solvents were removed under a stream of nitrogen, resulting
in a thin lipid film. The last traces of solvent were then removed under
reduced pressure (25 °C, 12 h, <0.2 Torr). To the dried film was added
1.0 mL of a 150 mM KCl solution that was 10% D2O and 90% H2O,
and the mixture was vortexed for 1 min. The dispersion was then
(m, 1 H), 4.00 (br, 1 H), 3.94 (s, 2 H), 3.78 (s, 2 H), 3.31 (m, 2 H),
3.16-3.14 (m, 4 H), 2.29-1.38 (m, 75 H), 1.02-0.91 (m, 16 H), 0.70
(s, 6 H). MALDI-TOF MS m/z 1178 ([M + Na]+).
Compound 13. To a solution of 12 (302 mg, 0.26 mmol) in
anhydrous DMF (5 mL) was added DHBT (100 mg, 0.64 mmol) and
DCC (100 mg, 0.5 mmol). After stirring for 3 h at room temperature,
spermine (26 mg, 0.13 mmol) and triethylamine (0.1 mL) were added.
The mixture was stirred overnight at room temperature and then poured
into diluted aqueous HCl (50 mL). The resulting precipitate was
collected by filtration and purified by chromatography on a silica gel
column, eluting with CHCl3/CH3OH/H2O (65/25/4, v/v/v), to give 13
(212 mg, 66%). 1H NMR (CD3OD, 500 MHz) δ: 4.23 (br, 2 H), 3.95
(br, 6 H), 3.80 (s, 4 H), 3.35-3.17 (m, 4 H), 3.16 (br, 8 H), 2.60 (br,
8 H), 1.97-1.41 (m, 166 H), 1.10-0.92 (m, 32 H), 0.71 (s, 12 H).
MALDI-TOF MS m/z 2478 ([M + H]+).
Conjugate 5. A solution of 13 (200 mg, 0.08 mmol) in TFA and
chloroform (5 mL, 1:1, v/v) was stirred for 4 h at room temperature.
9
J. AM. CHEM. SOC. VOL. 127, NO. 36, 2005 12729